BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26768958)

  • 1. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: A survey of current Australian practice.
    Kapurubandara S; Qin V; Gurram D; Anpalagan A; Merkur H; Hogg R; Brand A
    Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):606-11. PubMed ID: 26768958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.
    Mikami M; Nagase S; Yamagami W; Ushijma K; Tashiro H; Katabuchi H;
    J Gynecol Oncol; 2017 Jul; 28(4):e52. PubMed ID: 28541639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salpingectomy as a means to reduce ovarian cancer risk.
    Daly MB; Dresher CW; Yates MS; Jeter JM; Karlan BY; Alberts DS; Lu KH
    Cancer Prev Res (Phila); 2015 May; 8(5):342-8. PubMed ID: 25586903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operative Outcomes of Opportunistic Bilateral Salpingectomy at the Time of Benign Hysterectomy in Low-Risk Premenopausal Women: A Systematic Review.
    Kho RM; Wechter ME
    J Minim Invasive Gynecol; 2017 Feb; 24(2):218-229. PubMed ID: 27988392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' Perspectives and Practice Patterns Toward Opportunistic Salpingectomy in High- and Low-Risk Women.
    Jones NL; Schulkin J; Urban RR; Wright JD; Burke WM; Hou JY; McElwain CA; Tergas AI
    Cancer Invest; 2017 Jan; 35(1):51-61. PubMed ID: 28029807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
    Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current surgical practice of prophylactic and opportunistic salpingectomy in France].
    Chene G; de Rochambeau B; Le Bail-Carval K; Beaufils E; Chabert P; Mellier G; Lamblin G
    Gynecol Obstet Fertil; 2016; 44(7-8):377-84. PubMed ID: 27363615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of pelvic reconstructive surgeons on performance of opportunistic salpingectomy at the time of pelvic organ prolapse repair.
    Hassani DB; Mangel JM; Mahajan ST; Hijaz AK; El-Nashar S; Sheyn D
    Int Urogynecol J; 2019 Mar; 30(3):447-453. PubMed ID: 29656331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salpingectomy at the time of hysterectomy for benign gynaecological disease: A comparison of surgical approaches.
    Obermair HM; Borg EJ
    Aust N Z J Obstet Gynaecol; 2019 Oct; 59(5):725-729. PubMed ID: 31286477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
    Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
    Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evolution of and Evidence for Opportunistic Salpingectomy.
    Dilley SE; Straughn JM; Leath CA
    Obstet Gynecol; 2017 Oct; 130(4):814-824. PubMed ID: 28885426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Opportunistic Salpingectomy at the Time of Benign Hysterectomy.
    Till SR; Kobernik EK; Kamdar NS; Edwards MG; As-Sanie S; Campbell DA; Morgan DM
    J Minim Invasive Gynecol; 2018 Jan; 25(1):53-61. PubMed ID: 28712794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral salpingectomy as an option of permanent contraception at time of caesarean section: A survey of practice.
    Noori N; Edwards L; Anpalagan A; Athavale R; Burling M; Herbst U; Brand A; Kapurubandara S
    Aust N Z J Obstet Gynaecol; 2024 Feb; 64(1):72-76. PubMed ID: 37674327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
    Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
    Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of salpingectomy at the time of urogynecologic surgery.
    Bradley MS; Visco AG
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):385-9. PubMed ID: 26308195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
    Salvador S; Scott S; Francis JA; Agrawal A; Giede C
    J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey.
    Steenbeek MP; van Lieshout LAM; Aarts JWM; Piek JMJ; Coppus SFPJ; Massuger LFAG; Hermens RPMG; de Hullu JA
    J Gynecol Oncol; 2019 Jan; 30(1):e2. PubMed ID: 30479086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-reducing salpingectomy: Let us be opportunistic.
    Long Roche KC; Abu-Rustum NR; Nourmoussavi M; Zivanovic O
    Cancer; 2017 May; 123(10):1714-1720. PubMed ID: 28334425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Venkatesh KK; Clark LH; Stamilio DM
    Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.